The HDAC inhibitor, MPT0E028, enhances erlotinib-induced cell death in EGFR-TKI-resistant NSCLC cells
- M. C. Chen
- , C. H. Chen
- , J. C. Wang
- , A. C. Tsai
- , J. P. Liou
- , S. L. Pan
- , C. M. Teng
- Department of Pharmaceutical Sciences
- Graduate Institute of Pharmacognosy
- Ph.D. Program in Drug Discovery and Development Industry
- Master Program in Clinical Genomics and Proteomics
- Ph. D. Program in the Clinical Drug Development of Herbal Medicine
- TMU Research Center of Thoracic Medicine
- Department of Pharmacology
- TMU Research Center of Cancer Translational Medicine
- Ph.D. Program for Cancer Molecular Biology and Drug Discovery
- TMU Research Center of Drug Discovery
Research output: Contribution to journal › Article › peer-review
77
Link opens in a new tab
Citations
(Scopus)